Scholarlink

<p>Hypoxia is a potent stressor arising from insufficient oxygen delivery to the brain that can trigger neuronal damage and neurological complications. Oxidative stress (OS) and neuroinflammation have been implicated in hypoxia-induced neuropathologies. Clonidine, an alpha-2 adrenoceptor agonist, has been reported to exhibit neuroprotective effects in various animal models by reducing oxidative stress–mediated neurodegeneration. This study further explored its neuroprotective effects in mice subjected to chronic hypoxic stress (CHS). Male Swiss mice (20–25&#xa0;g) were randomly distributed into five groups (<i>n</i> = 8). Group 1 (non-stress control) and group 2 (stress control) received distilled water (10&#xa0;mL/kg), and groups 3–5 had clonidine (25, 50 and 100&#xa0;µg/kg), orally for 14&#xa0;days. Thirty minutes after each daily treatment, mice in groups 2–5 underwent a scheduled CHS protocol in a 300-mL sealed vessel for 20&#xa0;min, daily for 14&#xa0;days. Neurobehavioral changes and plasma corticosterone were determined. The malondialdehyde, nitrites, acetylcholinesterase (AChE), myeloperoxidase (MPO), antioxidant profile (SOD, GSH, catalase, GST), pro-inflammatory cytokines (IL-6 and TNF-α), and histomorphological changes were evaluated in the hippocampus, prefrontal cortex, and amygdala. Clonidine attenuated neurobehavioral deficits and reduced plasma corticosterone in mice exposed to CHS. Clonidine treatment reduced malondialdehyde, nitrites, pro-inflammatory cytokines, AChE, and MPO contents&#xa0;; enhanced antioxidant defense molecules; and preserved the neuronal cell integrity in the discrete brain regions of mice subjected to CHS. These findings suggest that clonidine mitigated CHS-induced behavioral impairments by reducing OS and pro-inflammatory cytokines, and may be repurposed as a promising therapeutic candidate for chronic stress-related disorders.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clonidine attenuates chronic hypoxic stress-induced behavioral abnormalities in male Swiss mice through suppression of oxidative stress and pro-inflammatory cytokines

  • 期刊论文

  • 发表日期：

    2025年12月6日

查看全文
  • Demilade Timothy Adebayo,
  • Clinton Ijirigho,
  • Paul Ademola Adeleke,
  • Emmanel Soremekun Oladimeji,
  • Favour Boluwatife Jegede,
  • Gbemisayo Adetomiwa Abbas,
  • Lily Oghenevovwero Otomewo,
  • Abayomi Mayowa Ajayi,
  • Solomon Umukoro

摘要

Hypoxia is a potent stressor arising from insufficient oxygen delivery to the brain that can trigger neuronal damage and neurological complications. Oxidative stress (OS) and neuroinflammation have been implicated in hypoxia-induced neuropathologies. Clonidine, an alpha-2 adrenoceptor agonist, has been reported to exhibit neuroprotective effects in various animal models by reducing oxidative stress–mediated neurodegeneration. This study further explored its neuroprotective effects in mice subjected to chronic hypoxic stress (CHS). Male Swiss mice (20–25 g) were randomly distributed into five groups (n = 8). Group 1 (non-stress control) and group 2 (stress control) received distilled water (10 mL/kg), and groups 3–5 had clonidine (25, 50 and 100 µg/kg), orally for 14 days. Thirty minutes after each daily treatment, mice in groups 2–5 underwent a scheduled CHS protocol in a 300-mL sealed vessel for 20 min, daily for 14 days. Neurobehavioral changes and plasma corticosterone were determined. The malondialdehyde, nitrites, acetylcholinesterase (AChE), myeloperoxidase (MPO), antioxidant profile (SOD, GSH, catalase, GST), pro-inflammatory cytokines (IL-6 and TNF-α), and histomorphological changes were evaluated in the hippocampus, prefrontal cortex, and amygdala. Clonidine attenuated neurobehavioral deficits and reduced plasma corticosterone in mice exposed to CHS. Clonidine treatment reduced malondialdehyde, nitrites, pro-inflammatory cytokines, AChE, and MPO contents ; enhanced antioxidant defense molecules; and preserved the neuronal cell integrity in the discrete brain regions of mice subjected to CHS. These findings suggest that clonidine mitigated CHS-induced behavioral impairments by reducing OS and pro-inflammatory cytokines, and may be repurposed as a promising therapeutic candidate for chronic stress-related disorders.